Mylan Settles With Cephalon Over Provigil Generics
This article was originally published in The Pink Sheet Daily
Executive Summary
Cephalon has reached a settlement with the third of four companies involved in a patent litigation suit over Cephalon's sleep disorder treatment Provigil (modafinil), the company announced Jan. 10
You may also be interested in...
Cephalon And Barr Reach Patent Settlements For Provigil, Actiq
Barr could gain up to two months of exclusivity for its Actiq generic.
Two Down, Two To Go: Cephalon Settles With Ranbaxy Over Provigil Generic
Nearly two weeks after settling with Teva, Cephalon has reached a settlement with Ranbaxy that is identical to Teva's deal for generic modafinil.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.